Spermatogenesis is a complex and dynamic process. Differentiated spermatocytes must undergo meiosis, during which the nuclear phase of the cells shifts from diploid (2C) to haploid (1C) via 4C. Spermiogenesis, which involves sperm head shaping and flagella formation, is a phenomenon characterized by unique and drastic changes in cell morphology,1 such as chromatin compaction by replacing histones with protamine2 and acrosome formation.3 In this process, the components of proteins necessary to build the flagella are transported on railed microtubules associated with intraflagellar transporter proteins (IFT)4–6 and motor proteins7,8 to elongate flagella9,10 with the removal of the cytoplasm.11 This same microtubule-based skirt-like transient structure called the manchette is supposed to play an important role in protein delivery and sperm head shaping.1,12
Mammalian testes express specific genes required to regulate complex sperm differentiation processes. However, the functions of proteins encoded by these genes are unknown.13–15 Therefore, elucidation of individual gene functions and accumulation of knowledge is required for an integrated understanding of spermatogenesis. Indeed, DNA analysis of patients with infertility has elucidated the associated genetic factors.16 Furthermore, the use of a knockout (KO) mouse model by the development of a simplified method using the CRISPR/Cas9 system allows for determination of required gene products.17,18
Here, we focused on mouse Axdnd1 (axonemal dynein light chain domain containing 1), which is an orthologous gene of human AXDND1(C1orf125). However, despite its expression in the testes, its function is yet to be characterized. To uncover the requirement of the protein product AXDND1 in spermatogenesis, we generated gene KO mice. It has recently been shown that Axdnd1-deficient male mice display infertility.19 However, AXDND1 had not been analyzed using antibodies against this protein, so we aim to reveal the localization pattern of AXDND1 in spermatogenesis via immunostaining using a home-grown antibody and to deepen our understanding of the function of AXDND1.
MATERIALS AND METHODS AnimalsC57BL/6N mice were purchased from SLC and maintained under a 12-h light/dark cycle.
ChemicalsAll reagents were purchased from Nacalai Tesque unless otherwise stated.
Preparation of antibodies against AXDND1An antibody against AXDND1 was prepared using a recombinant protein as outlined previously.20 The partial cDNA sequence of AXDND1(CCDS83611.1) corresponding to 958–1111 aa was amplified by PCR, inserted into the His-tagged pCold-pros2 vector (Takara Bio), and transformed into DH5a competent E. coli (Takara Bio). The selected clone was further transformed into the BL21 (DE3) E. coli strain (Takara Bio), and protein expression was induced with IPTG. After the tagged protein was eluted with imidazole and enzymatically digested by HRV3C protease, the pros2 tag was removed, and the purified protein was immunized into rabbits to produce polyclonal antibodies. The resulting IgG-purified antiserum was used in this study.
mRNA and protein expression patterns in tissuescDNA libraries were obtained from several tissues, and mRNA expression was analyzed. Tissues collected and stored for RNA extraction were homogenized in Sepazol. Total RNA was isolated according to the manufacturer's instructions. A total of 500 ng of total RNA were reverse-transcribed (Revertra ace; Toyobo) and used for PCR along with the appropriate paired primers for Axdnd1 (F: 5′- AAAGACCTGGTGACTCAGCG-3′ and R: 5′- GTCATTAAGGGCTACGGCGA-3′ [generated 636 bp]) and β-actin (F: 5′-AAGAGCTATGAGCTGCCTGA-3′ and R: 5′-CAGGAGGAGCAATGATCTTG-3′ [generated 270 bp]). The designed primer pair spanned different exons. The cycling program was as follows: 94°C for 3 min, denaturation at 94°C for 10 s, 35 cycles of annealing at 55°C for 15 s, extension at 68°C for 20 s, and further extension at 68°C for 5 min.
From tissues (8–12 weeks old mice), proteins were extracted using RIPA buffer containing 1% protease inhibitor (Nacalai Tesque, #25955) and the concentration was measured using the BCA method. A total of 10 μg proteins were separated by SDS-PAGE, transferred to a PVDF membrane, and treated with a commercial blocking buffer (Blocking One Nacalai Tesque) for 1 h at room temperature (RT). The membranes were subsequently washed with TBS containing 0.1% Tween 20 (TBS-T) and incubated with anti-AXDND1 antiserum (1:2000) or anti-β-actin (1:5000; Santa Cruz Biotechnology, #SC-47778) overnight at 4°C. After washing twice with TBS-T for 5 min each, they were further incubated with anti-rabbit HRP-conjugated antibody (1:2000; Promega #W4011) for 2 h at RT, followed by the addition of HRP substrate. Images were captured using the LAS 3000 imaging system (Fujifilm).
Generation of Axdnd1 KO miceAxdnd1 KO mice of the C57BL/6N strain were generated by iGONAD as previously reported.21 Briefly, crRNA was designed with the following sequence: TGTCCATCACGTTGCTCAACTGG (underlined PAM sequence) to target exon 7 of the Axdnd1 allele because the InterPro database predicted the presence of axonemal dynein light chain domain at position 209–367 that appeared to be important for protein function (Figure 1B). In addition, crRNA and tracrRNA (Integrated DNA Technologies) were annealed at 94°C for 2 min, mixed with Cas9, and injected into the oviduct at E0.7 of plug confirmed mice. DNA genotyping was performed using DNA extracted from the clipped toes. Primer sequences used were F: 5′-ACACTCTCCTTACCCACGGA-3′ and R: 5′-ACCAGTCTGTCCCTTTGATCTT-3′. The PCR product from the mutant gDNA was Sanger sequenced to determine successful deletion. In order to fix the mutation in the strain, the F0 founder was mated with wild type mice (WT), and the resulting F1 heterozygous male and female mice were crossed to obtain an F2 generation containing homozygous mutants. The established strain was maintained by sibling breeding and used in the current study.
FIGURE 1. mRNA expression profiling and knockout (KO) strategy. (A) Axdnd1 mRNA expression in mouse tissues as determined by RT-PCR. Total RNA (500 ng) was reverse-transcribed, and cDNA was used for RT-PCR. Deionized water was used as a negative control. (B) Diagram of Axdnd1 allele and amino acid sequence. Arrows indicate the primer loci designed for genotyping. InterPro database predicted axonemal dynein light chain domain in 209–367 aa. The C-terminal region of 958–1111 aa was referenced for the recombinant protein for antigen. (C) DNA sequence of Axdnd1−/− mice. A 10 bp deletion was induced via cocktail injection of crRNA, tracrRNA, and Cas9 protein. Note that mRNA translation occurred in the reverse strand. (D) Disruption of the subsequent in-frame translation 10 bp deletion in the mutated mouse DNA. (E) Patterning of each PCR genotype
A single 8-week-old male mouse (WT, Axdnd1+/−, or Axdnd1−/−) was caged with two 8-week-old female WT mice for 4 weeks. Mating was verified by confirming the presence of vaginal plugs. The plugged females were then replaced with new mice. Five male mice of each genotype were used in the experiment. Litter size was scored for the females who had plugs.
Histological analysisAfter measuring the body weights of both WT and Axdnd1−/− mice (8–12 weeks old), they were euthanized by cervical dislocation. Testes were then removed and weighed. The testes and epididymis were fixed in Bouin's solution (Sigma-Aldrich) overnight, gradually dehydrated by stepwise substitution with ethanol and xylene at different concentrations, and finally embedded in paraffin. Sections (4-µm-thick) were rehydrated, stained with periodic acid–Schiff (PAS), and examined under a microscope (Olympus BX50).
TUNEL assayApoptotic cells were counted using a TUNEL assay. The sections were TUNEL-stained using an in situ apoptosis detection kit (Takara Bio #MK500) following the manufacturer's instructions. Briefly, rehydrated sections were treated with proteinase K for 15 min at RT, labeled with FITC-dUTP by TdT enzyme for 1 h at RT, and covered with a glass coverslip. The samples were examined under a fluorescence microscope (Keyence BZ-X710) using 25 randomly chosen seminiferous tubules sections. Merged signals from the counterstained nuclei were counted. Testes samples were collected from three WT and KO mice.
Immunohisto- and immunocytochemistryThe collected testes were fixed overnight in 4% PFA-PBS and embedded in paraffin after dehydration. Sections (4-µm-thick) were rehydrated, treated with antigen-retrieval buffer (pH 9.0; Histo VT One; Nacalai Tesque) for 20 min at 90°C, and washed with tap water for 10 min. The sections were then treated with a commercial blocking buffer (Blocking One; Nacalai Tesque) for 1 h at RT and incubated with the AXDND1 antibody (1:200) overnight at 4°C. The samples were washed three times with PBS containing 0.1% Tween 20 (PBS-T) for 5 min and incubated with Alexa Fluor 488 (Thermo Fisher Scientific #A21206) for 1 h at RT. The coverslips were then observed under a fluorescence microscope, as previously described in the TUNEL assay.
For staining of individual cells, samples were prepared as follows: Testes were minced in 1 ml of DMEM using scissors to release cells from seminiferous tubules and were incubated for 30 min at 37°C. The cell suspension was washed by centrifugation and fixed with 4% PFA-PBS for 10 min at RT. After washing three times with PBS, the suspension was mounted on a glass slide and air-dried. Slides were permeabilized with 0.1% Triton X-100/PBS for 5 min at 37°C, washed again three times with PBS, and treated with blocking solution for 1 h at RT. Afterward, the slides were incubated with primary antibodies overnight at 4°C at the following dilution: α-tubulin (Santa Cruz Biotechnology, #sc-32293: 1:100). The slides were washed three times with PBS and incubated for 1 h at RT. Alexa fluor 568 conjugated lectin PNA (Thermo Fisher Scientific, #L32458:1:200) was used to specify the differentiation stage, and Hoechst 33342 was used for DNA counterstaining.
Statistical analysisThe unpaired Student's t-test (GraphPad Prism 9; GraphPad Software) was performed for comparison with the WT group. Values are represented as the mean ± SD. Differences were considered significant at p < 0.05, indicated as p < 0.05 (*) or p < 0.01 (**).
RESULTS mRNA expression patterns of Axdnd1Axdnd1 mRNA expression patterns in several tissues were compared (Figure 1A). mRNA expression was detected in the brain, lungs, spleen, testes, and intestine.
Generation of the mutant mice strainTo understand the contribution of Axdnd1 to fertility, we generated a KO mouse strain. Specific crRNA targeting the PAM sequence in exon 7 was co-injected with Cas9 protein, and the subsequent 10 bp deletion was confirmed by sequencing (Figure 1C,E). With this deletion, the stop codon (TGA) appeared in frame at the position coding Leu221 (Figure 1D), resulting in termination of translation.
Axdnd1−/− mouse model showed sterility due to impaired spermatid elongationThe mutant mice were viable and showed no abnormalities. However, fertility tests demonstrated that Axdnd1−/− males were sterile, as shown in Table 1. The average number of pups from each genotype was WT: 8.7 ± 1.3, Axdnd1+/−: 8.3 ± 1.3, and Axdnd1−/−: 0. Further analysis revealed that the size of the testes of Axdnd1−/− mice (53 ± 3 mg) was significantly smaller than that of Axdnd1+/− (107 ± 8 mg) and WT (106 ± 11 mg) mice (Figure 2A,B). As the significant decrease in testes weight suggested cell loss, the apoptotic frequency was counted using the TUNEL assay (Figure 2C). Axdnd1−/− testes showed significantly higher positive signals (Axdnd1−/− 119.7 ± 16.8 vs. WT 20.3 ± 4.73), indicating higher rates of apoptosis. Representative images of the TUNEL patterns are shown in Figure 2D.
TABLE 1 Fertility test of WT, Axdnd1+/−, and Axdnd1−/− male mice
Genotype | n | Plugs | Litters | Pups | Pups/Litters |
WT | 5 | 47 | 33 | 287 | 8.7 ± 1.3 |
Axdnd1 +/− | 5 | 33 | 25 | 208 | 8.3 ± 1.3 |
Axdnd1 −/− | 5 | 36 | 0 | 0 | 0** |
Axdnd1−/− males showed infertility. Each male genotype was mated with two WT females, Plugs: Number of females with plugs in the mating period. Litters: Number of pregnancies. Pups: Total number of each litter. Statistically analyzed pups/litters are shown as mean ± SD. Different letters represent significant differences compared to WT. **; p < 0.01.
FIGURE 2. Axdnd1−/− male testes have smaller size and increased TUNEL-positive cells. (A) Comparison of total body and testes weight for each mouse genotype (n = 5). (B) Smaller testes size in Axdnd1−/− mice. Representative morphology of WT and Axdnd1−/− testes at 8 weeks. Bar = 2 mm. (C) Average number of TUNEL-positive cells in 25 seminiferous tubules of WT and Axdnd1−/− testes (n = 3). Error bars represent SD. **; p [less than] 0.01, ns; no significance. (D) Images showing that frequent TUNEL-positive cells (green) were observed in Axdnd1−/− testes counterstained by Hoechst 33342 (blue). Bars =50 µm
Histological analysis revealed malformations during spermatid differentiation (Figure 3E,F). Elongated spermatids with malformed heads were detected in mutant mice at steps 10–12 of spermatid (panel of stage XII). After step 13, the number of spermatids decreased (panel of stage IV to V) and almost disappeared after step 15 (panel of stage Ⅶ to Ⅷ). Moreover, few spermatozoa were observed in the cauda epididymis (Figure 3G,H) and none retained their complete morphology (Figure 3I).
FIGURE 3. Axdnd1−/− mice exhibit abnormal spermatogenesis. PAS-stained images of WT vs. Axdnd1−/− seminiferous tubules at stage VII ~ VIII (A and D), XII (B and E), and IV ~ V (C and F). Abnormally head-shaped spermatozoa, corresponding to step 12 of spermatids in the XII panel (E; arrows), gradually disappeared in step 15, as shown in stage IV and V panels (F; arrows). WT and Axdnd1−/− cauda-epididymis sections (G and H). Few spermatozoa stored in the cauda epididymis (H). Bars = 50 µm. (I) Representative morphology of sperm from the cauda epididymis in WT and Axdnd1−/− mice. Nuclei and flagella stained with acetylated α-tubulin (red) or DNA (blue). Bars = 10 µm
Using a home-grown prepared rabbit polyclonal antibody, AXDND1 protein expression was analyzed in various tissues, revealing an intense signal in the testes and weak expression in the lungs and spleen (Figure 4A). Loss of AXDND1 expression in the mutant testes was observed (Figure 4B), and a specific immunostaining pattern was confirmed (Figure 4C).
FIGURE 4. Validation of the specificity of the AXDND1 antibody. (A) Analysis of AXDND1 expression in whole tissues. From each tissue, 10 µg of protein was used for SDS-PAGE. Ponceau staining to validate the sample loading. (B) Confirming protein loss of AXDND1 in the mutant testes. (C) Validation of anti-AXDND1 antibody for specific immunostaining. KO section testes-stained same condition is shown as negative control. Arrows indicate the non-specific signals. AXDND1 (Green), DNA (Blue). Bars = 100 µm
Observations of different stages of seminiferous tubules demonstrated cytoplasmic expression of the protein from spermatocytes to elongated spermatids (Figure 5). AXDND1 signals were first detected in middle pachytene spermatocytes at stage VII. The signals remained throughout meiosis until early spermatids. Furthermore, immunocyte staining using testicular cells spread on glass also revealed that the AXDND1 expression was detected in spermatids until step 8 (Figure 6C), weakened in step 9 (Figure 6D), and almost disappeared in step 10 (Figure 6E).
FIGURE 5. Staging of AXDND1 expression patterns in testicular sections. Staging of the seminiferous epithelium cycle with AXDND1 expression in WT testes (bars = 10 µm); AXDND1 (green), and DNA (blue). ESTs, elongated spermatids; M-ⅡSCs, meiosis-II spermatocytes; PSCs, pachytene spermatocytes; RSTs, round spermatids; ZSCs, zygotene spermatocytes
FIGURE 6. AXDND1 expression in early spermiogenesis. Expression patterns of AXDND1 during early spermiogenesis (steps 1 [A], 4 or 5 [B], 7 or 8 [C], 9 [D], and 10 [E]). AXDND1 (green), PNA (red), and DNA (blue). In the AXDND1 monochromatic panels on left side, signals are shown in gray for contrast. Axdnd1−/− round spermatids were used as a negative control. Bars = 10 µm
We investigated the malformation of spermatids and manchette structures of WT and Axdnd1−/− mice by immunostaining for α-tubulin (Figure 7). The manchette of elongating stage spermatids in Axdnd1−/− mice was abnormally longer (Figure 7E-G) or had disorganized tubulin structures (Figure 7H) compared to WT mice. These results indicated that AXDND1 participates in the formation of manchettes.
FIGURE 7. Abnormal formation of manchette structure in mutant testes. Immunostained manchette structures from elongating spermatids. Arrows indicate the length of the manchette between the peri- and post-nuclear directions. Representative WT or Axdnd1−/− spermatids of step 9 (A and E) and from steps 10 to 12 (B, C, D, F, G, and H). Some mutant spermatids had disorganized manchettes (H) compared to WT (D). α-tubulin (red) and nuclei (blue) are shown. Bars = 10 µm
The aim of this study was to understand the function of the uncharacterized protein AXDND1. Axdnd1 mRNA expression was detected in the brain, lungs, spleen, and intestines, while low protein expression was detected in both the lungs and spleen (Figure 1A). For many testicular flagellar genes, expression levels in the brain and lungs showed a similar pattern.
To uncover the contribution of Axdnd1 to fertility, KO mouse models were generated, and we demonstrated that the loss of AXDND1 causes sterility (Table 1). The decrease in testes weight, explained by an increase in apoptosis, was confirmed by the TUNEL assay (Figure 2). In addition to spermiogenesis, AXDND1 may have functions involved in cell survival. Histological examination by PAS staining and immunohistochemistry further revealed malformation during sperm head formation and a lack of spermatids with a retained fine flagellar structure, indicating that sterility was induced by the degeneration of germ cells during spermatid differentiation (Figure 3).
Immunostaining with a usable home-grown antibody revealed cytosolic expression patterns from pachytene stage spermatocytes to round spermatids for the first time (Figure 5), which has not shown in the early study. According to a recent study19 that used cells fractionated for each developmental stage, protein expression was detected in round spermatids but not in spermatocytes, which differs from the results of our microscopic examination. Since we could not find a description of how the authors validated the purity of the enriched fraction, it is thought that this was due to differences in the protocol.
Axdnd1−/− spermatids showed a disorganized manchette structure (Figure 7); however, colocalization of AXDND1 was not observed in our immunocytochemical analysis. It is possible that the amount of protein distributed in the manchette was extremely small, below the limit of detection of the antibody, or that the effect on manchette formation could be determined in earlier steps. Given that Axdnd1 plays a role in these early events, it is possible that microtubule aggregates appear and bind to related proteins.11,22
According to previous reports, dynein light chain proteins are involved in sperm motility. Dynein light chain 1 LC8 type 1 (DYNII1), a component of the dynein motor complex, was expressed during steps 9–16 of spermiogenesis in a rat model, in contrast to the AXDND1 expression pattern.23 Another dynein light chain protein is the t-complex-coding protein DYNLT (Tctex). Both Dynlt1 and Dynlt2 were discovered in the t-haplotype allele, which is expressed in the sperm.24–26 In human spermatozoa, a decrease in protein levels and loss of localization of DYNLT1 in flagella was observed in infertile patients; thus, DYNLT1 is thought to be a potential regulator of motility.27 Targeting disruption of Dyntl2, one of the three copies of Tcte3, increased the frequency of apoptosis and decreased sperm motility.28 One of the highlights of this study is that, unlike these light chain proteins, AXDND1 deficiency induces severe damage to the head and flagellar formation prior to its effects on motility. Phenotypic similarities have been reported in many gene KO mouse models. IFT proteins carry materials for flagellar building, and some gene mutants display disruption of head shaping.4–6,29 Kinesin superfamily proteins also participate in axoneme building, and Kif3a inactivation in mouse spermatids results in abnormal manchette formation.30 In addition, the ciliary protein Fused (STK36), a putative serine-threonine kinase, was shown to interact with KIF27.31 Interactions of AXDND1 with these proteins should be evaluated in future studies.
In conclusion, we demonstrated that Axdnd1 deficiency impairs the formation of the sperm head and flagella, suggesting it is a novel essential gene for spermiogenesis. The resulting phenotype differed from the predicted motility effects of the deficient phenotype of the known axoneme dynein light chain genes. This also includes the possibility that the role of the axonemal dynein light chain domain in AXDND1 is different or that other parts are responsible. Including the question why the disruption of Axdnd1 causes DNA damage, by demonstrating binding to relevant dynein heavy chains in the domain, the discovery of partner proteins and identification of their interacting binding sites will clearly explain and expand our understanding of spermiogenesis.
Moreover, according to recently reported results,19 deleterious heterozygous mutations in AXDND1 were found in non-obstructive azoospermia (NOA) patients. Therefore, Axdnd1 is essential for human spermatogenesis. This indicates that Axdnd1 deficiency may be the cause of NOA and that Axdnd1 KO mice could be used as a model for future NOA studies. Here, we observed the behavior of AXDND1 using the antibody, which represents a major advance in elucidating the role of this protein. Further research using AXDND1-specific antibodies and a NOA mouse model is expected to make significant contributions to future NOA treatment options.
ACKNOWLEDGMENTSDr. M. Ikawa (Osaka University) provided helpful advice on the study plan.
CONFLICT OF INTERESTThe authors have no conflicts of interest directly relevant to the content of this study.
ANIMAL STUDIES AND APPROVAL BY ETHICS COMMITTEEAll animal experiments were approved by the Animal Care and Use Committee of the Research Institute of Tohoku University (2021 Agr-004). All the procedures involving animal experiments were performed according to the institutional and national guidelines for the care and use of laboratory animals.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Purpose
Spermiogenesis, the process of deformation of sperm head morphology and flagella formation, is a phenomenon unique to sperm. Axonemal dynein light chain proteins are localized to sperm flagella and are known to be involved in sperm motility. Here, we focused on the gene axonemal dynein light chain domain containing 1 (Axdnd1) with the aim to determine the function of its protein product AXDND1.
Methods
To elucidate the role of AXDND1 in spermatogenesis, we generated Axdnd1 knockout (KO) mice using the CRISPR/Cas9 system. The generated mice were subjected to fertility tests and analyzed by immunohistochemistry.
Result
The Axdnd1 KO mouse exhibited sterility caused by impaired spermiogenesis during the elongation step as well as abnormal nuclear shaping and manchette, which are essential for spermiogenesis. Moreover, AXDND1 showed enriched testicular expression and was localized from the mid‐pachytene spermatocytes to the early spermatids.
Conclusion
Axdnd1 is essential for spermatogenesis in the mouse testes. These findings improve our understanding of spermiogenesis and related defects. According to a recent report, deleterious heterozygous mutations in AXDND1 were found in non‐obstructive azoospermia (NOA) patients. Therefore, Axdnd1 KO mice could be used as a model system for NOA, which will greatly contribute to future NOA treatment studies.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Laboratory of Animal Reproduction and Development, Graduate School of Agricultural Science, Tohoku University, Sendai, Japan
2 Laboratory of Aquacultural Biology, Graduate School of Agricultural Science, Tohoku University, Sendai, Japan
3 Division of Molecular Genetics, Shigei Medical Research Institute, Okayama, Japan
4 Division of Dynamic Proteome and IDAC Fellow Research Group for DNA Repair and Dynamic Proteome Institute of Development, Aging and Cancer (IDAC), Tohoku University, Sendai, Japan